Gapping down
In reaction to disappointing earnings/guidance: CREE -17.4%, AYI -3.2%,MON -1.4%, WYNN -0.5%
M&A news: AGN -1.4% (Pfizer confirms its and Allergan (AGN) will terminate their planned merger)
Select metals/mining stocks trading lower: BBL -2.4%, MT -2.2%, BHP -2%,HMY -1.9%, RIO -1.8%, ABX -1.6%, GG -1.3%, GDX -1.2%
Other news: DRWI -5.2% (following 45%+ move higher), HTA -2.5% (prices 5.2 mln shares of common stock at $28.90 per share), DOC -1.1% (upsizes offering by 4.5 mln shares and prices 22.5 mln common shares at $17.85)
Analyst comments: MAT -3.6% (downgraded to Hold on valuation at Stifel), SIMO -2.4% (downgraded to Neutral from Buy at Ladenburg Thalmann), CCOI -2% (downgraded to Neutral from Buy at Citigroup),NVDA -1.4% (downgraded to Hold at Stifel ), CMI -1.1% (downgraded to Neutral from Buy at Buckingham Research), TKC -0.7% (downgraded to Neutral from Overweight at JP Morgan), CF -0.5% (downgraded to Neutral from Buy at BofA/Merrill)
In reaction to disappointing earnings/guidance: CREE -17.4%, AYI -3.2%,MON -1.4%, WYNN -0.5%
M&A news: AGN -1.4% (Pfizer confirms its and Allergan (AGN) will terminate their planned merger)
Select metals/mining stocks trading lower: BBL -2.4%, MT -2.2%, BHP -2%,HMY -1.9%, RIO -1.8%, ABX -1.6%, GG -1.3%, GDX -1.2%
Other news: DRWI -5.2% (following 45%+ move higher), HTA -2.5% (prices 5.2 mln shares of common stock at $28.90 per share), DOC -1.1% (upsizes offering by 4.5 mln shares and prices 22.5 mln common shares at $17.85)
Analyst comments: MAT -3.6% (downgraded to Hold on valuation at Stifel), SIMO -2.4% (downgraded to Neutral from Buy at Ladenburg Thalmann), CCOI -2% (downgraded to Neutral from Buy at Citigroup),NVDA -1.4% (downgraded to Hold at Stifel ), CMI -1.1% (downgraded to Neutral from Buy at Buckingham Research), TKC -0.7% (downgraded to Neutral from Overweight at JP Morgan), CF -0.5% (downgraded to Neutral from Buy at BofA/Merrill)